Live Q&A session: Using the BOPA Digital Verification Passport

Tuesday 5th December 2023 at 15:00 – 16:00 GMT – Click HERE to register

The BOPA Education and Training Subcommittee would like to invite you a live Q&A session on using the BOPA Digital Verification Passport.

Netty will be covering some FAQS asked by members since the launch and participants will have the opportunity to ask any other questions related to the passport.

 

If you wish to submit a question in advance please email verificationpassport@bopa.org.uk with the title – webinar question

 

This webinar is FREE for all BOPA members and associates.

Register for your free place now via the link at the top of the page. (Note: You must be at least a BOPA FREE associate.) Join here

 

Please note this session will not be recorded.

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article